Answers are grounded in this paper and cite their sources.
Three cardinal manifestations of neoplasia, namely inflammation, immune dysfunction, and coagulopathy are also seen in patients with severe SARS-CoV-2 infection, providing a biological rationale for testing selected anticancer drugs for their ability to control the symptoms and/or modify the course of COVID-19.
No takes yet. Share an insight, caveat, or question.
Saini et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: